Company / Working Capital
CHINA PHARMA HOLDINGS, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$5.1M
FY2025
5-year range
-$6.8M / -$823.7K
FY2021-FY2025
Trend
-189.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from -$7M in FY2022 to $7M in FY2016.
Based on SEC 10-K filings.
-$5M in FY2025.
Declined from -$823,731 to -$5M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital decreased 189.3% year-over-year.
- Peak working capital was recorded in FY2016.
- Lowest working capital in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.1M | -189.3% |
| FY2024 | -$1.7M | -112.1% |
| FY2023 | -$823.7K | +87.8% |
| FY2022 | -$6.8M | -377.1% |
| FY2021 | -$1.4M | +76.7% |
| FY2020 | -$6.1M | -36.2% |
| FY2019 | -$4.5M | -242.4% |
| FY2018 | -$1.3M | -142.6% |
| FY2017 | $3.1M | -57.0% |
| FY2016 | $7.1M | -41.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026